This graph shows pharmaceutical companies that have the most complementary protection certificates (SPCs) in Ireland.
SPC is used in the EU and identify others to promote pharmaceutical innovation by
Compensation for the long time required for regulatory approval of medicines. Countries covered by strategic programming
Enter into force only after the expiration of the corresponding general patent, usually a maximum of 5 years.
The total duration of the exclusive market for the general patent and the SPC can not exceed 15 years, but an extension of six months
Can be obtained by responding to a request for testing on children.
For a different perspective, see the pharmaceutical companies that own SPC products in most countries
The pharmaceutical companies that most of the small and medium enterprises in Ireland are owned are:
- Gilead Sciences Inc
- Janssen Brodts
- Boehringer Ingelheim
- Merck Sharp Duma
- Sanofi Aventis us
For more information on how to help DrugPatentWatch meet your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Copyright © DrugPatentWatch. Originally published in which pharmaceutical companies have most SMEs in Ireland?